Common questions and misconceptions about caffeine supplementation : what does the scientific evidence really show?
Caffeine is a popular ergogenic aid that has a plethora of evidence highlighting its positive effects. A Google Scholar search using the keywords "caffeine" and "exercise" yields over 200,000 results, emphasizing the extensive research on this topic. However, despite the vast amount of available data, it is intriguing that uncertainties persist regarding the effectiveness and safety of caffeine. These include but are not limited to: 1. Does caffeine dehydrate you at rest? 2. Does caffeine dehydrate you during exercise? 3. Does caffeine promote the loss of body fat? 4. Does habitual caffeine consumption influence the performance response to acute caffeine supplementation? 5. Does caffeine affect upper vs. lower body performance/strength differently? 6. Is there a relationship between caffeine and depression? 7. Can too much caffeine kill you? 8. Are there sex differences regarding caffeine's effects? 9. Does caffeine work for everyone? 10. Does caffeine cause heart problems? 11. Does caffeine promote the loss of bone mineral? 12. Should pregnant women avoid caffeine? 13. Is caffeine addictive? 14. Does waiting 1.5-2.0 hours after waking to consume caffeine help you avoid the afternoon "crash?" To answer these questions, we performed an evidence-based scientific evaluation of the literature regarding caffeine supplementation.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
---|---|
Enthalten in: |
Journal of the International Society of Sports Nutrition - 21(2024), 1 vom: 31. März, Seite 2323919 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Antonio, Jose [VerfasserIn] |
---|
Links: |
---|
Themen: |
3G6A5W338E |
---|
Anmerkungen: |
Date Completed 12.03.2024 Date Revised 14.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/15502783.2024.2323919 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM36955907X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM36955907X | ||
003 | DE-627 | ||
005 | 20240314235436.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240311s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/15502783.2024.2323919 |2 doi | |
028 | 5 | 2 | |a pubmed24n1329.xml |
035 | |a (DE-627)NLM36955907X | ||
035 | |a (NLM)38466174 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Antonio, Jose |e verfasserin |4 aut | |
245 | 1 | 0 | |a Common questions and misconceptions about caffeine supplementation |b what does the scientific evidence really show? |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 12.03.2024 | ||
500 | |a Date Revised 14.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Caffeine is a popular ergogenic aid that has a plethora of evidence highlighting its positive effects. A Google Scholar search using the keywords "caffeine" and "exercise" yields over 200,000 results, emphasizing the extensive research on this topic. However, despite the vast amount of available data, it is intriguing that uncertainties persist regarding the effectiveness and safety of caffeine. These include but are not limited to: 1. Does caffeine dehydrate you at rest? 2. Does caffeine dehydrate you during exercise? 3. Does caffeine promote the loss of body fat? 4. Does habitual caffeine consumption influence the performance response to acute caffeine supplementation? 5. Does caffeine affect upper vs. lower body performance/strength differently? 6. Is there a relationship between caffeine and depression? 7. Can too much caffeine kill you? 8. Are there sex differences regarding caffeine's effects? 9. Does caffeine work for everyone? 10. Does caffeine cause heart problems? 11. Does caffeine promote the loss of bone mineral? 12. Should pregnant women avoid caffeine? 13. Is caffeine addictive? 14. Does waiting 1.5-2.0 hours after waking to consume caffeine help you avoid the afternoon "crash?" To answer these questions, we performed an evidence-based scientific evaluation of the literature regarding caffeine supplementation | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Ergogenic aid | |
650 | 4 | |a exercise | |
650 | 4 | |a performance | |
650 | 4 | |a supplement | |
650 | 7 | |a Caffeine |2 NLM | |
650 | 7 | |a 3G6A5W338E |2 NLM | |
650 | 7 | |a Performance-Enhancing Substances |2 NLM | |
700 | 1 | |a Newmire, Daniel E |e verfasserin |4 aut | |
700 | 1 | |a Stout, Jeffrey R |e verfasserin |4 aut | |
700 | 1 | |a Antonio, Brandi |e verfasserin |4 aut | |
700 | 1 | |a Gibbons, Maureen |e verfasserin |4 aut | |
700 | 1 | |a Lowery, Lonnie M |e verfasserin |4 aut | |
700 | 1 | |a Harper, Joseph |e verfasserin |4 aut | |
700 | 1 | |a Willoughby, Darryn |e verfasserin |4 aut | |
700 | 1 | |a Evans, Cassandra |e verfasserin |4 aut | |
700 | 1 | |a Anderson, Dawn |e verfasserin |4 aut | |
700 | 1 | |a Goldstein, Erica |e verfasserin |4 aut | |
700 | 1 | |a Rojas, Jose |e verfasserin |4 aut | |
700 | 1 | |a Monsalves-Álvarez, Matías |e verfasserin |4 aut | |
700 | 1 | |a Forbes, Scott C |e verfasserin |4 aut | |
700 | 1 | |a Gomez Lopez, Jose |e verfasserin |4 aut | |
700 | 1 | |a Ziegenfuss, Tim |e verfasserin |4 aut | |
700 | 1 | |a Moulding, Blake D |e verfasserin |4 aut | |
700 | 1 | |a Candow, Darren |e verfasserin |4 aut | |
700 | 1 | |a Sagner, Michael |e verfasserin |4 aut | |
700 | 1 | |a Arent, Shawn M |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of the International Society of Sports Nutrition |d 2004 |g 21(2024), 1 vom: 31. März, Seite 2323919 |w (DE-627)NLM174118449 |x 1550-2783 |7 nnns |
773 | 1 | 8 | |g volume:21 |g year:2024 |g number:1 |g day:31 |g month:03 |g pages:2323919 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/15502783.2024.2323919 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 21 |j 2024 |e 1 |b 31 |c 03 |h 2323919 |